참고문헌
- Ambudkar SV, Kim IW, Sauna ZE (2006). The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur J Pharm Sci, 27, 392-400. https://doi.org/10.1016/j.ejps.2005.10.010
- Baldissera VD, de Mattos AA, Coral GP, et al (2012). Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma. Ann Hepatol, 11, 899-906.
- Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 8, 790-801.
- Choi JH, Lim HY, Joo HJ, et al (2002). Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer, 86, 1578-85. https://doi.org/10.1038/sj.bjc.6600305
- Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
- Dean M (2009). ABC transporters, drug resistance and cancer stem cells. J Mammary Gland Biol Neoplasia, 14, 3-9. https://doi.org/10.1007/s10911-009-9109-9
- Ferlay J, Shin HR, Bray F (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
- Fromm MF (2002). The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev, 54, 1295-310. https://doi.org/10.1016/S0169-409X(02)00064-9
- Gottesman MM (2002). Mechanisms of cancer drug resistance. Annu Rev Med, 53, 615-27. https://doi.org/10.1146/annurev.med.53.082901.103929
- Kim JJ, Tannock IF (2005). Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer, 5, 516-25. https://doi.org/10.1038/nrc1650
- Lacueva FJ, Calpena R, Medrano J, et al (2000). Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer, 89, 21-8. https://doi.org/10.1002/1097-0142(20000701)89:1<21::AID-CNCR4>3.0.CO;2-T
- Nobili S, Landini I, Giglioni B, Mini E (2006). Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets, 7, 861-79. https://doi.org/10.2174/138945006777709593
- Oliveira J, Felipe AV, Chang PY, et al (2012). Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer. Mol Med Rep, 6, 395-8.
- Ren YQ, Han JQ, Cao JB, Li SX, Fan GR (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 13, 5451-4. https://doi.org/10.7314/APJCP.2012.13.11.5451
- Salama NN, Yang Z, Bui T, Ho RJ (2006). MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J Pharm Sci, 95, 2293-308. https://doi.org/10.1002/jps.20717
- Silva GA, Gamarra CJ, Girianelli VR, Valente JG (2011). Cancer mortality trends in Brazilian state capitals and other municipalities between 1980 and 2006. Rev Saude Publica, 45, 1009-18. https://doi.org/10.1590/S0034-89102011005000076
- Song W, Jiang R, Zhao CM (2012). Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells. Asian Pac J Cancer Prev, 13, 5619-25. https://doi.org/10.7314/APJCP.2012.13.11.5619
- Ueda K, Cornwell MM, Gottesman MM, et al (1986). The MDR1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun, 141, 956-62. https://doi.org/10.1016/S0006-291X(86)80136-X
- Wei WZ, Yu JP, Li J, Liu CS, Zheng XH (2005). Evaluation of contrast-enhanced helical hydro-CT in staging gastric cancer. World J Gastroenterol, 11, 4592-5.
- Wu DD, Zhang JX, Li J, Dong WG (2014). Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and metaanalysis. Asian Pac J Cancer Prev, 15, 3021-7. https://doi.org/10.7314/APJCP.2014.15.7.3021
- Xie HL, Su Q, He XS, et al (2004). Expression of p21(WAF1) and p53 and polymorphism of p21(WAF1) gene in gastric carcinoma. World J Gastroenterol, 10, 1125-31.
- Zhang WY, Zhang WJ, Bai Y, et al (2013). Impact of adjuvant chemotherapy cycles on prognosis of resectable stomach cancer: a retrospective analysis. Asian Pac J Cancer Prev, 14, 381-6. https://doi.org/10.7314/APJCP.2013.14.1.381
- Zhu CY, Lv YP, Yan DF, Gao FL (2013). Knockdown of ABCB1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac J Cancer Prev, 14, 6757-60. https://doi.org/10.7314/APJCP.2013.14.11.6757
피인용 문헌
- Genetic Variation in the ABCB1 Gene May Lead to mRNA Level Chabge: Application to Gastric Cancer Cases vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8467
- Influence of Genotype and Haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the Incidence of Breast Cancer - a Case-Control Study in Jordan vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.261